FIELD: aseptics. SUBSTANCE: for treating septic shock, cachexia, and other life threatened inflammatory conditions, muramyl peptide compounds are proposed, preferably N-acetylglucosaminyl-N-acetylmuramyl-L-alanyl- D-glutamic acid. Drug is not pyrogenic and/or reduces intensity of endotoxin-caused weight loss symptoms and/or hypophagia; and/or reduces production of FNO; and/or reduces stimulation of macrophages to process endotoxins. EFFECT: increased treatment safety.
| Title | Year | Author | Number |
|---|---|---|---|
| SPECIFIC COMBINED THERAPY OF MALIGNANT TUMOURS WITH CYTOSTATIC AGENT AND ITS MODIFYING AGENT | 2015 |
|
RU2571551C1 |
| METHOD FOR PREPARING PHARMACOLOGICALLY ACCEPTABLE MIXTURE OF SUBSTANCES CONTAINING LOW-MOLECULAR INGREDIENTS OF CELL WALL PEPTIDOGLYCANE OF GRAM-NEGATIVE BACTERIA AND POSSESSING IMMUNOSTIMULATORY ACTIVITY | 2008 |
|
RU2478644C2 |
| METHOD FOR OBTAINING N-ACETYLGLUCOSAMINYL-N-ACETYLMURAMYL-L-ALANYL-D-GLUTAMIC ACID | 2015 |
|
RU2573991C1 |
| COMPOSITION COMPRISING LOW-MOLECULAR FRAGMENTS OF PEPTIDOGLICANE OF GRAM-NEGATIVE BACTERIA FOR PREVENTING OR TREATING OF HUMAN DISEASES | 2009 |
|
RU2441906C2 |
| COMPOSITION OF SOLUBLE MONOMERIC AND OLIGOMERIC FRAGMENTS OF PEPTIDOGLYCAN OF THE CELL WALL OF GRAM-NEGATIVE BACTERIA, METHODS FOR PRODUCTION AND APPLICATION THEREOF | 2020 |
|
RU2765270C1 |
| PROCESS FOR PREPARING MURAMYL PEPTIDES | 1995 |
|
RU2083588C1 |
| POLYMER FRAGMENT OF PEPTIDOGLICAN OF GRAM-NEGATIVE BACTERIA CELL WALL, METHOD OF ITS OBTAINING AND ITS APPLICATION AS IMMUNOSTIMULATOR | 2006 |
|
RU2412197C2 |
| METHOD FOR MODELLING OF RESPIRATORY BURST OF POLYMORPHONUCLEAR LEUKOCYTES | 0 |
|
SU1644206A1 |
| METHOD FOR SIMULATING IMMUNE-DEPENDENT ALLOGENIC PREGNANCY LOSS IN LABORATORY MICE | 2012 |
|
RU2511107C1 |
| METHOD OF PRODUCING DERIVATIVES OF MURAMYLDIPEPTIDE | 0 |
|
SU1190990A3 |
